DPP4 and lung carcinoma: To further clarify the role of DPP4i, we conducted a SEER (Surveillance Epidemiology and Endpoint Research)-Medicare analysis of colorectal cancer and lung cancer patients, which also showed a similar trend toward beneficial effects associated with CD26/DPP4 inhibition (13).